1. Clipstone NA, Crabtree GR: Calcineurin is the key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drug.Ann NY Acad Sci USA 1993, 696:20-30.

2. Brunn GJ, Hudson CC, Sekulic A, et al.: Phosphorylation of the transla-tional repressor PHAS-I by the mammalian target of rapamycin. Science 1997, 277:99-101.

3. de Mattos AM, Olyaei AJ, Bennet WM: Pharmacology of immuno-suppressive medications used in renal diseases and transplantation.Am J Kid Dis 1996, 28:631-637.

4. de Mattos AM, Olyaei AJ, Bennet WM: Mechanism and risks of immunosuppressive therapy. In Immunologic Renal Disease. Edited by Neilson EG, Couser WG. Philadelphia: Lippincott-Raven; 1996:861-885.

5. Barry JM: Immunosuppressive drugs in renal transplantation: a review of the regimens. Drug 1992, 44:554-566.

6. Powelson JA, Cosimi AB: Antilymphocyte globulin and monoclonal antibodies. In Kidney Transplantation: Principles and Practice, edn 4. Edited by Morris PJ. Philadelphia: WB Saunders Co; 1994.

7. English J, Evan A, Houghton DC, Bennett WM: Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 1987, 44:135-141.

8. Red Book: Drug TopicsĀ®. Montvale, NJ: Medical Economics Company, Inc., 1998.

9. First MR: An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ trans-plantation.Am J Kid Dis1997, 29:303-317.

0 0

Post a comment